Our sincere thanks to NSERC for 5 more years of support, in the form of a Discovery Grant. We look forward to developing more tools to enable discovery in the chemical biology of transglutaminases!
Congratulations to Sydney Acton, who recently defended her MSc thesis! Her multidisciplinary project encompassed organic synthesis, kinetics, fluorescence spectroscopy and cell microscopy. Way to go, Master Sydney!
Great news!! The Keillor, Vanderhyden and Lorimer labs were awarded a 5-year grant to develop TG2 inhibitors as anti-cancer therapeutics. Our thanks to the Pharmaceutical Sciences panel for their confidence!
Eric Gates was awarded a Keith Fagnou scholarship to pursue his MSc studies.
Thanks to Amber, Ann, Het and Scott for a great summer together. Welcome to Beth and Nancy, who will be doing their Honours projects with us! And especially to Eric, who has joined us for his MSc. Eric will be… Read moreWelcome!
New article “Structure–Activity Relationships of Potent, Targeted Covalent Inhibitors That Abolish Both the Transamidation and GTP Binding Activities of Human Tissue Transglutaminase” was recently published in the Journal of Medicinal Chemistry. Congratulations to co-authors Abdullah Akbar and Nicole McNeil, and… Read moreNew article in J. Med. Chem!
Kim Apperley does it again… Presenting her third poster at a CSC, Kim brings home her third first-place prize! Way to go, Kim!
The Keillor group welcomes two new undergraduate summer students to team, Andrea Sim and Sarah Eisinga!
Congradulations to two of our undergraduate Honours students, Nicholas Brunet-Filion and Joshua Reed on their acceptance into medical school!
Dr. Jeffrey Keillor receives the Bernard Belleau award (2017) for distinguished contribution to the field of medicinal chemistry through research involving biochemical or organic chemical mechanisms! http://www.cheminst.ca/awards/csc-awards/bernard-belleau-award